Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Linking signalling pathways, thymic stroma integrity and autoimmunity.

Jens Derbinski1, Bruno Kyewski

  • 1Division of Developmental Immunology, Tumor Immunology Program, German Cancer Research Center, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany.

Trends in Immunology
|July 26, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conventional and Neo-antigenic Peptides Presented by β Cells Are Targeted by Circulating Naïve CD8+ T Cells in Type 1 Diabetic and Healthy Donors.

Cell metabolism·2018
Same author

Thymic tuft cells promote an IL-4-enriched medulla and shape thymocyte development.

Nature·2018
Same author

An efficient protocol for in vivo labeling of proliferating epithelial cells.

Journal of immunological methods·2018
Same author

Islet-reactive CD8<sup>+</sup> T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors.

Science immunology·2018
Same author

T cells specific for post-translational modifications escape intrathymic tolerance induction.

Nature communications·2018
Same author

Epitope-Specific Tolerance Modes Differentially Specify Susceptibility to Proteolipid Protein-Induced Experimental Autoimmune Encephalomyelitis.

Frontiers in immunology·2017
Same journal

IL-33 scripts cancer immunity.

Trends in immunology·2026
Same journal

Mitochondrial Ca<sup>2+</sup> signaling: A metabolic rheostat defining tumor and immune cell fate.

Trends in immunology·2026
Same journal

Cross-priming underlies the efficacy of antibody-drug conjugates and immunotherapy combinations.

Trends in immunology·2026
Same journal

Gut microbiome metabolites meet immunometabolism in inflammatory bowel disease.

Trends in immunology·2026
Same journal

Metabolic regulatory nodes of the inflammasome and inflammatory cell death.

Trends in immunology·2026
Same journal

Parental leave in immunology - 6.

Trends in immunology·2026
See all related articles

Tumor necrosis factor receptor-associated factor 6 (TRAF6) is crucial for the development of mature medullary thymic epithelial cells (mTECs). This finding impacts understanding of central tolerance and autoimmunity risk.

Area of Science:

  • Immunology
  • Cell Biology
  • Developmental Biology

Background:

  • Medullary thymic epithelial cells (mTECs) are vital for establishing self-tolerance.
  • mTECs express tissue-restricted antigens, crucial for educating T cells.
  • Dysregulation of mTEC development can lead to autoimmunity.

Purpose of the Study:

  • To investigate the role of signaling pathways in mTEC development.
  • To identify key molecular players in the differentiation and maturation of mTECs.

Main Methods:

  • Analysis of signaling pathways involved in mTEC development.
  • Identification of essential components regulating mTEC maturation.

Main Results:

  • Tumor necrosis factor receptor-associated factor 6 (TRAF6) was identified as essential for mTEC development.

Related Experiment Videos

  • TRAF6 plays a critical role in a newly discovered signaling pathway governing mTEC maturation.

    • Conclusions:

    • TRAF6 is a key regulator of mTEC development.
    • Understanding TRAF6 signaling is important for central tolerance and preventing autoimmunity.